CVRx Inc

Yesterday’s bearish medium-term stance was invalidated by late-June’s F candle and Bullish Pivot Point closing above the 9/21 EMAs, signaling structural repair. CVRX now sits in an early Stage 1 consolidation below the 50 DMA with medium-term bias turned Bullish. Short-term timing is Neutral; execution should be deferred by stalking pullbacks into the 9/21 EMA support or lower consolidation boundary. A decisive close below the 9/21 EMA region would invalidate this bullish posture.

• ↑Devoted Health’s coverage decision increases institutional reimbursement and patient access for Barostim.
• ↑Q2 2026 revenue rose 16% YoY to $15.7 M; net loss narrowed to $14 M (–$0.53/sh), showing cost control.
• ↓Full-year revenue guidance cut from $63–67 M to $58–60 M; shares slid 60% on the revision.